Abstract
Background
The CARdiorenal PEDIatric EMergency (CARPEDIEM) machine was originally designed to perform only continuous venovenous hemofiltration (CVVH) in neonatal and pediatric patients. In some cases, adequate convective clearance may not be reached because of a limited blood flow. In such conditions, the application of diffusive clearance [continuous venovenous hemodialysis (CVVHD)] would help optimize blood purification. In this study, the CARPEDIEM™ machine was modified to enable the circulation of dialysis through the filter allowing testing of the performance of CARPEDIEM™ machine in CVVHD.
Methods
Three different polyethersulfone hemodialyzers (surface area = 0.1 m2, 0.2 m2, and 0.35 m2, respectively) were tested in vitro with a scheduled combination of plasma flow rates (Qp = 10-20-30 ml/min) and dialysis fluid flow rate (Qd = 5-10-15 ml/min). Three sessions were performed in co-current and one in counter-current configuration (as control) for each filter size. Clearance was measured from the blood and dialysate sides and results with mass balance error greater than 5 % were discarded.
Results
Urea and creatinine clearances for each plasma/dialysate combination are reported: clearance increase progressively for every filter proportionally to plasma flow rates. Similarly, clearances increase progressively with dialysate flow rates at a given plasma flow. The clearance curve tends to present a steep increase for small increases in plasma flow in the range below 10 ml/min, while the curve tends to plateau for values averaging 30 ml/min. As expected, the plateau is reached earlier with the smaller filter showing the effect of membrane surface-area limitation. At every plasma flow, the effect of dialysate flow increase is evident and well defined, showing that saturation of effluent was not achieved completely in any of the experimental conditions explored. No differences (p > 0.05 for all values) were obtained in experiments using whole blood instead of plasma or using co-current versus counter-current dialysate flow configuration.
Conclusions
Although plasma flow and filter surface give an important contribution to the level of clearance urea and creatinine, it appears evident that dialysate flow plays an essential role in the blood purification process, justifying the use of CVVHD versus CVVH in case of high dialysis dose requirement and/or limited blood flow rate.
Similar content being viewed by others
References
Sohn YB, Paik KH, Cho HY, Kim SJ, Park SW, Kim ES, Chang YS, Park WS, Choi YH, Jin DK (2012) Continuous renal replacement therapy in neonates weighing less than 3 kg. Korean J Pediatr 55:286–292
Rajpoot DK, Gargus JJ (2004) Acute hemodialysis for hyperammonemia in small neonates. Pediatr Nephrol 19:390–395
Askenazi DJ, Ambalavanan N, Goldstein SL (2009) Acute kidney injury in critically ill newborns: what do we know? What do we need to learn? Pediatr Nephrol 24:265–274
Symons JM, Brophy PD, Gregory MJ, McAfee N, Somers MJ, Bunchman TE, Goldstein SL (2003) Continuous renal replacement therapy in children up to 10 kg. Am J Kidney Dis 41:984–989
Goldstein SL, Somers MJ, Baum MA, Symons JM, Brophy PD, Blowey D, Bunchman TE, Baker C, Mottes T, McAfee N, Barnett J, Morrison G, Rogers K, Fortenberry JD (2005) Pediatric patients with multi-organ dysfunction syndrome receiving continuous renal replacement therapy. Kidney Int 67:653–658
Askenazi DJ, Goldstein SL, Koralkar R, Fortenberry J, Baum M, Hackbarth R, Blowey D, Bunchman TE, Brophy PD, Symons J, Chua A, Flores F, Somers MJ (2013) Continuous renal replacement therapy for children </=10 kg: a report from the prospective pediatric continuous renal replacement therapy registry. J Pediatr 162(587–592), e583
Ronco C, Ricci Z (2015) Pediatric continuous renal replacement: 20 years later. Intensive Care Med 41:985–993
Walters S, Porter C, Brophy PD (2009) Dialysis and pediatric acute kidney injury: choice of renal support modality. Pediatr Nephrol 24:37–48
Ansari N (2011) Peritoneal dialysis in renal replacement therapy for patients with acute kidney injury. Int J Nephrol 2011:739794
Goldstein SL (2009) Overview of pediatric renal replacement therapy in acute kidney injury. Semin Dial 22:180–184
Coulthard MG, Crosier J, Griffiths C, Smith J, Drinnan M, Whitaker M, Beckwith R, Matthews JN, Flecknell P, Lambert HJ (2014) Haemodialysing babies weighing <8 kg with the Newcastle infant dialysis and ultrafiltration system (Nidus): comparison with peritoneal and conventional haemodialysis. Pediatr Nephrol 29:1873–1881
Hothi DK (2014) Designing technology to meet the therapeutic demands of acute renal injury in neonates and small infants. Pediatr Nephrol 29:1869–1871
Ronco C, Garzotto F, Ricci Z (2012) CA.R.PE.DI.E.M. (Cardio-Renal Pediatric Dialysis Emergency Machine): evolution of continuous renal replacement therapies in infants. A personal journey. Pediatr Nephrol 27:1203–1211
Ronco C, Garzotto F, Brendolan A, Zanella M, Bellettato M, Vedovato S, Chiarenza F, Ricci Z, Goldstein SL (2014) Continuous renal replacement therapy in neonates and small infants: development and first-in-human use of a miniaturised machine (CARPEDIEM). Lancet 383:1807–1813
Askenazi D, Ingram D, White S, Cramer M, Borasino S, Coghill C, Dill L, Tenney F, Feig D, Fathallah-Shaykh S (2016) Smaller circuits for smaller patients: improving renal support therapy with Aquadex. Pediatr Nephrol 31:853–860
Kaplan A (1996) Continuous arteriovenous hemofiltration and related therapies. In: Boston KA (ed) Replacement of renal function by dialysis, pp 390–417
Parakininkas D, Greenbaum LA (2004) Comparison of solute clearance in three modes of continuous renal replacement therapy. Pediatr Crit Care Med 5:269–274
Relton S, Greenberg A, Palevsky PM (1992) Dialysate and blood flow dependence of diffusive solute clearance during CVVHD. ASAIO J 38:M691–M696
Bonnardeaux A, Pichette V, Ouimet D, Geadah D, Habel F, Cardinal J (1992) Solute clearances with high dialysate flow rates and glucose absorption from the dialysate in continuous arteriovenous hemodialysis. Am J Kidney Dis 19:31–38
Bunchman TE, Brophy PD, Goldstein SL (2008) Technical considerations for renal replacement therapy in children. Semin Nephrol 28:488–492
Brophy PD, Somers MJ, Baum MA, Symons JM, McAfee N, Fortenberry JD, Rogers K, Barnett J, Blowey D, Baker C, Bunchman TE, Goldstein SL (2005) Multi-centre evaluation of anticoagulation in patients receiving continuous renal replacement therapy (CRRT). Nephrol Dial Transplant 20:1416–1421
Acknowledgments
The authors would like to thank the non-profit organization A.A.R.VI for providing support for laboratory measurements and plasma procurement.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The author(s) declare that they have no competing interests
Additional information
Anna Lorenzin and Francesco Garzotto contributed equally to this work.
Rights and permissions
About this article
Cite this article
Lorenzin, A., Garzotto, F., Alghisi, A. et al. CVVHD treatment with CARPEDIEM: small solute clearance at different blood and dialysate flows with three different surface area filter configurations. Pediatr Nephrol 31, 1659–1665 (2016). https://doi.org/10.1007/s00467-016-3397-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-016-3397-2